| Nicole Kiyo Tsuchiya Imanaka, LCSW | |
|
91-1841 Fort Weaver Rd, Ewa Beach, HI 96706-1909 | |
| (808) 748-3146 | |
| Not Available |
| Full Name | Nicole Kiyo Tsuchiya Imanaka |
|---|---|
| Gender | Female |
| Speciality | Community/behavioral Health |
| Location | 91-1841 Fort Weaver Rd, Ewa Beach, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568935989 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4342 (Hawaii) | Secondary |
| 251S00000X | Community/behavioral Health | 4342 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Kiyo Tsuchiya Imanaka, LCSW 721 Hahaione St, Honolulu, HI 96825-1030 Ph: () - | Nicole Kiyo Tsuchiya Imanaka, LCSW 91-1841 Fort Weaver Rd, Ewa Beach, HI 96706-1909 Ph: (808) 748-3146 |
News Archive
Today, the Prevention Research Center for Healthy Neighborhoods of Case Western Reserve University release new health data from Cleveland neighborhood groups on three of the most pressing public health concerns: obesity, hypertension, and diabetes.
On Feb. 4, Senators John McCain and Byron Dorgan introduced the Dietary Supplement Safety Act of 2010 (DSSA), that if passed, will restrict Americans' access to nutritional supplements. Hotze Enterprises, a world leader in the alternative health care industry, is strongly opposed to this legislation being passed, and encourages consumers to take action.
As the March 1 deadline for the sequester approaches, news outlets analyze the impact budget cuts might have on the U.S. economy in general and on Medicare specifically.
Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company.
EndoChoice, Inc. strengthens its position as the leader in endoscopy industry with the launch of a new CEU program and a complete line of products focused on efficient and effective endoscope reprocessing.
› Verified 7 days ago